Mirum Pharmaceuticals, Inc.
MIRM
$67.72
-$2.37-3.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 120.41% | 76.21% | 41.94% | 33.28% | 39.65% |
| Total Depreciation and Amortization | 0.12% | 3.45% | 6.85% | 21.20% | 127.46% |
| Total Amortization of Deferred Charges | 4.48% | 4.91% | 4.59% | 4.26% | 3.16% |
| Total Other Non-Cash Items | 39.73% | 38.14% | 67.40% | -37.03% | 63.44% |
| Change in Net Operating Assets | 1,085.80% | -519.45% | -147.18% | 77.41% | 78.17% |
| Cash from Operations | 896.01% | 416.59% | -112.89% | 69.50% | 121.86% |
| Capital Expenditure | -3.31% | 83.83% | -215.38% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 88.57% | 91.00% | -- | 133.05% | -159.52% |
| Cash from Investing | 87.65% | 90.93% | -124,007.69% | 132.05% | 90.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 316.67% | 19.16% | 427.72% | 159.48% | -98.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 316.67% | 19.16% | 427.72% | 200.51% | -98.13% |
| Foreign Exchange rate Adjustments | 296.59% | 1,970.59% | 833.63% | -1,376.85% | 127.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 633.60% | 123.58% | -164.67% | 97.22% | -273.23% |